International Conference on Immunometabolic Diseases and Clinical Research

This session will explore the intricate metabolic pathways that govern immune cell function and differentiation. Understanding these mechanisms is crucial for developing targeted therapies for immunometabolic diseases.

This track focuses on bridging basic research and clinical applications in immunometabolism. Presentations will highlight innovative strategies to translate findings into effective treatments for metabolic disorders.

This session will examine the interplay between inflammation and metabolic dysregulation in various diseases. Discussions will center on how immune responses contribute to the pathogenesis of metabolic disorders.

This track will address the role of clinical immunology in understanding and managing metabolic health. Participants will share insights on immune profiling and its implications for metabolic disease outcomes.

This session will review the latest advancements in immunometabolic therapies and their clinical applications. Experts will discuss novel therapeutic strategies aimed at modulating immune responses to improve metabolic health.

This track will delve into the regulatory mechanisms of the immune system in the context of metabolic disorders. Presentations will highlight how immune regulation can influence disease progression and treatment.

This session will focus on the identification and validation of biomarkers relevant to immunometabolic diseases. Researchers will present findings that could enhance diagnostic and therapeutic approaches.

This track will explore the interactions between diet, gut microbiota, and immune metabolism. Discussions will emphasize how these factors contribute to the development and management of metabolic diseases.

This session will investigate how cellular metabolism influences immune function and responses. Insights into metabolic reprogramming of immune cells will be discussed in relation to disease mechanisms.

This track will showcase novel experimental models used to study immunometabolic diseases. Presenters will discuss the advantages and limitations of these models in advancing our understanding of disease mechanisms.

This session will provide a platform for discussing the global burden of immunometabolic diseases and the disparities in clinical research. Participants will share insights on collaborative efforts to address these challenges.